Park Avenue Securities’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,556
Closed -$259K 1018
2022
Q4
$259K Sell
3,556
-151
-4% -$11.9K ﹤0.01% 1041
2022
Q3
$311K Buy
3,707
+375
+11% +$32.3K 0.01% 895
2022
Q2
$265K Buy
3,332
+1,198
+56% +$116K 0.01% 970
2022
Q1
$221K Buy
+2,134
New +$177K ﹤0.01% 1059

Other funds holding NTR

Park Avenue Securities's NTR Position: Q1 2023 in Review

Park Avenue Securities sold out of Nutrien (NTR) in Q1 2023, closing a stake of 3,556 shares — an estimated $259K sold.

Park Avenue Securities first reported a position in NTR in Q1 2022 and held it in 4 quarters. The position peaked at $311K in Q3 2022. 666 funds tracked by Wall St. Rank hold NTR as of Q1 2023.

  • Park Avenue Securities reported no remaining Nutrien position as of Q1 2023 after selling out during the quarter.
  • Park Avenue Securities sold 3,556 Nutrien shares in Q1 2023, an estimated $259K.
  • Park Avenue Securities first reported a position in Nutrien in Q1 2022 and held it in 4 quarters.
  • Park Avenue Securities's Nutrien position peaked at $311K in Q3 2022.
  • 666 funds tracked by Wall St. Rank held Nutrien as of Q1 2023.

Based on Park Avenue Securities's 13F filing for Q1 2023, filed 18 Apr 2023.